摘要 |
The described invention provides a biodegradable, biocompatible delivery system of flowable sustained release microparticulate composition of a substantially pure crystalline form of a bioactive agent such as, for example, nimodipine, a process of preparing a therapeutic form of a substantially pure crystalline form of the bioactive agent and a method for treating an interruption of a cerebral artery in a subarachnoid space at risk of interruption caused by brain injury in a mammal, which reduces signs or symptoms of at least one delayed complication associated with brain injury. |
申请人 |
MACDONALD, R., LOCH;DAVIS, CARA, R.;BURTON, KEVIN;WINCHESTER, GARY;STELLA, ANGELA, R. |
发明人 |
MACDONALD, R., LOCH;DAVIS, CARA, R.;BURTON, KEVIN;WINCHESTER, GARY;STELLA, ANGELA, R. |